Objectives: Evidence supports the safety and effectiveness of outpatient parenteral antibiotic therapy (OPAT). A registered nurse (RN)-managed multidisciplinary team OPAT model was implemented at our hospital. We evaluated the impact of the new OPAT model on readmissions during OPAT and other core OPAT processes.
Introduction
Outpatient parenteral antibiotic therapy (OPAT) is a programme that delivers intravenous (iv) antimicrobial drugs to patients in an outpatient setting as an alternative to inpatient care. OPAT is a widely accepted and safe therapeutic option for treating patients with serious infections requiring long-term iv antibiotics. OPAT has been used in industrialized countries for over 40 years, with substantial data to support its clinical efficacy and cost-effectiveness. [1] [2] [3] The potential benefits of OPAT, when delivered in a structured programme, include reduced length of stay, lowered demands on inpatient beds, lower out-of-pocket costs for patients, greater patient satisfaction and reduced nosocomial infections. [4] [5] [6] However, owing to the disparate nature of hospital finance in the USA, these benefits are difficult to measure and demonstrate.
In brief, hospitals in the USA comprise a mixture of government hospitals, funded by local, state and/or federal tax dollars, and private hospitals, funded by donations, grants and payments from patients and their insurance carriers ('payers') for services and procedures they perform. Our hospital is in the latter group and operates as a privately funded not-for-profit hospital. Each patient must enrol in a health insurance plan to access healthcare services, which may be prohibitively expensive. Many patients are eligible to receive commercial/for-profit health insurance through employer-based plans or on the open market. Indigent patients, elderly patients or those who have served in the military are also eligible for state and federally subsidized insurance programmes.
When a patient leaves the hospital but still requires professional healthcare services, the patient enters the realm of 'long-term care'. The structure of long-term care remains unchanged since it V C The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.
was reviewed in 1985 by Doty et al. 7 Patients can continue to receive iv infusions after hospital discharge in a variety of settings: dialysis centres, daytime infusion clinics, at home using a home infusion company or in a residential skilled nursing facility (SNF; also called a nursing home). Typically, home infusion companies send a nurse to the home weekly to take medications, draw blood and provide catheter care, while patients administer their own infusion on a daily basis using pre-programmed pumps or gravity flow bags. Patients in SNFs remain in the facility under nursing care for the duration of their treatment.
Relevant to OPAT, private hospitals bear no costs for a patient's care after they are discharged; these costs, including OPAT care, are borne by the patient and the payer. Medicare, the primary health insurance payer for adults over 65 years, 8 is not universally accepted by home infusion companies. Therefore, some Medicare patients requiring OPAT are compelled to enter SNFs for treatment. 9 Since hospitals are only reimbursed for inpatient services, many do not offer or coordinate OPAT care. In many cases, infectious disease (ID) specialists working in outpatient clinics assume this responsibility pro bono. The ID physician following up an OPAT patient may be associated with the discharging hospital or may be an independent practitioner with no relationship to the hospital. A survey of ID physicians in the USA confirmed that OPAT patients are often not followed up in a formally established programme. 10 Although hospitals do not pay for outpatient care, they are penalized when patients require readmission within 30 days of discharge. The Medicare Hospital Readmissions Reductions Program (HRRP), which applies to all states except Maryland, calculates an expected readmission rate based on a hospital's case mix. If the hospital exceeds that expected rate, it is penalized by a reduction in payments across all Medicare admissions, up to a maximum of 2% of hospital revenue ($528 million nationwide in 2017).
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Maryland has a state-administered penalty system that functions in a similar fashion to incentivize hospitals to reduce readmission rates. 12 Pertinent to OPAT, studies have shown that coordinating care with post-acute providers and clarifying discharge instructions result in lower readmission rates.
Best practice guidelines for OPAT recommend careful patient selection, weekly monitoring of laboratory values and clinical status, structured communication, written care coordination plans and monitoring of outcomes. 13, 14 Studies have shown that patients whose weekly laboratory values are not available to clinicians have a higher risk of readmission than those whose laboratory results are monitored weekly. 15 In addition, there is strong supportive evidence that OPAT programmes delivered by coordinated and multidisciplinary teams have better outcomes than those followed up in an ad hoc fashion. 16, 17 The ideal OPAT team comprises a multidisciplinary group of practitioners, including ID physicians, registered nurses (RNs), wound care specialists, pharmacists, billing staff and a medical office coordinator, with access to ancillary services such as social work and physical therapy on an ad hoc basis. 14, 17, 18 The OPAT model of care at our hospital underwent a change almost 2 years ago from a solo nurse practitioner model to a nurse-managed multidisciplinary team model. The primary aim of this study was to evaluate the impact of this new care model on core OPAT processes and all-cause hospital readmissions at 30 days.
Patients and methods

Study design and data source
We conducted a hospital-based, retrospective cohort study of all OPAT discharges from the Johns Hopkins Bayview Medical Center before and after the formation of a nurse-managed multidisciplinary team. Patients who were discharged on OPAT from 1 November 2013 to 31 June 2017 were considered for the analysis (n " 611).
Patient medical record numbers and selected clinical data were entered into a tracking database by the OPAT programme (nurse practitioner, physician or nurse) at the time of OPAT referral. At the time of the study, all potential OPAT discharges were manually reviewed and records that met any of the following exclusion criteria were excluded: (i) patient did not leave the hospital on OPAT (n " 12); (ii) patient died shortly after OPAT initiation (n " 6); (iii) patient moved to a different country or was imprisoned (n " 3); and (iv) subsequent OPAT course for the same patient (n " 73) (Figure 1 ).
Relevant patient characteristics obtained for this study included demographic data, All Patients Refined Diagnosis Related Groups (APR-DRG) severity-of-illness score, outpatient versus inpatient OPAT start, site of OPAT care [home infusion, SNF/long-term acute care (LTAC) or dialysis centre], hospital length of stay (LOS) and opioid dependence. Demographic and clinical patient characteristics were extracted from electronic health records (EHR) administrative data using the institutional data warehouse (PREMIER QualityAdvisor TM Database, Premier Inc., Charlotte, NC, USA; March 2015 release). In cases where patient characteristics were missing from the institutional data warehouse, the information was manually extracted from the EHR. Compliance with ID clinic visits, number of phone calls to site of care placed and evaluation of received laboratory tests for their correctness were collected from a subset of patients (n " 398).
Description of study site and OPAT models of care
Johns Hopkins Bayview Medical Center is a 440 bed academic hospital that serves the Baltimore community and surrounding areas. ID consultations are available for inpatients and outpatients and are conducted by fellowship-trained ID physicians. The inpatient physician is often not the same physician who follows the patient up in the clinic setting post-discharge, but recommendations are readily viewable in the medical record.
For all OPAT discharges, sites of care were asked to submit weekly laboratory tests as per ID protocol. During all time periods, orders were communicated to the sites of care via the discharge summary and/or via fax from the hospital's home infusion coordinator. Laboratory studies were performed at independent laboratories located in the vicinity where the Mansour et al.
patient was receiving care. Many SNFs sent blood samples to local hospitals for analysis. Lab results were sent via facsimile back to the SNF, but were not visible to the discharging hospital physicians owing to the lack of a common medical record system in the USA. Results from these tests were faxed to our ID clinic by the home infusion company or SNF. During the pre-intervention period ('pre-RN'), OPAT patients were followed up by an ID nurse practitioner who tracked laboratory tests using a paper filing system, managed patient phone calls and saw patients in clinic. No dedicated physician oversight, pharmacy staff or case management resources were available during this time. The Division of Infectious Disease was unable to support the programme owing to heavy financial losses and discontinued the OPAT service in October 2015, leaving the care coordination to the primary care physicians and surgical specialists. In response to this system disruption, prominent surgical and medical specialists wrote letters to the hospital administration requesting stable funding for an IDmanaged OPAT service. A workgroup was commissioned to create a costeffective service model, which constructed the programme described below.
In the intervention period ('post-RN'), starting in May 2016, the hospital funded the formation of a multidisciplinary OPAT team which consisted chiefly of a full-time nurse with physician oversight (10% time), pharmacy support and limited clerical support for assistance with phone calls. Written protocols were drafted for weekly laboratory monitoring, dose adjustments per pharmacy protocols and after-hours communication plans, amongst others. The qualifications of the nurse included certification as an RN (2 year degree after a bachelor's programme) with experience in infusion delivery, line management, wound care and symptom assessment.
The RN was given primary responsibility for patient tracking postdischarge, with an emphasis on obtaining weekly laboratory results from community sites and triaging incoming calls from patients and sites of care. Ongoing patient management included six main processes (Table 1) .
First, the RN received referrals from the ID consult service and performed an intake visit with the patient prior to discharge. For patients with a recent history of opioid dependence, the RN engaged the patient in a behaviour contract consenting to line removal if it was used for illicit substances.
Second, the RN entered patient information into the REDCap electronic data capture tool hosted at Johns Hopkins University and maintained an active census in the EHR. 19 Third, the RN received faxed printouts of laboratory test results from outside facilities, scanned them into the EHR and routed them to the physician, with e-mail notification of concerning values. The RN also pursued missing laboratory tests by placing phone calls to nursing homes or home infusion companies on a weekly basis.
Fourth, the RN responded to calls from patients and nursing facilities regarding issues arising during the antibiotic course. Common phone calls included patient adverse events (i.e. diarrhoea or rash), critical laboratory values, vascular access issues and reports of patient and/or caregiver noncompliance.
Fifth, the RN relayed relevant clinical information to the physician for recommendations or order changes, which were relayed back to the site of care. The Johns Hopkins Home Care Group pharmacists were also empowered to change doses (but not drugs) to alleviate the burden on the ID physicians. All clinical activities were documented in the EHR.
Sixth, the RN inputted programme performance measures into the tracking database, including missing laboratory tests, patient noncompliance, readmissions and safety events.
The overseeing ID physician reviewed laboratory results sent by the RN, contacted patients and staff to address medication side effects, referred patients to the hospital as needed and saw patients in the post-discharge clinic every 2-3 weeks until therapy was completed and as needed after iv antibiotics were discontinued. Other ID physicians within the same practice saw OPAT patients who could not be accommodated by the patient's primary OPAT physician.
Study definitions and outcomes
The 3M APR-DRG severity subclass is a calculated measure of the extent of physiological decompensation or organ system loss of function and is used to measure the complexity of a hospital's patient case mix. 20 The metric takes into account the patient's multiple comorbidities and any complications of the index hospitalization and is useful for predicting readmissions. 21 APR-DRG and point of origin were available for inpatients only and not patients initiated on OPAT as outpatients ('outpatient starts').
Considering that the vast majority of patients started their antimicrobial course on the first or second day of their admission, treatment duration was calculated by adding hospital LOS prior to OPAT and anticipated OPAT duration. For outpatient OPAT starts, treatment duration was the same as their anticipated OPAT duration. The anticipated duration of treatment was based on the recommendation of the final ID consult note during the patient's hospital stay/visit. Final treatment duration was determined by the OPAT nurse practitioner (pre-RN) or physician (post-RN) based on the patient's clinical condition.
The primary outcome of this study was all-cause readmission to any facility part of the Johns Hopkins Health System within 30 days of OPAT discharge. The secondary outcomes were patients with no laboratory tests available, patients with wrong laboratory tests, patients who missed at least one of their ID clinic appointments, telephone calls to the site of care and variable direct hospital costs associated with OPAT readmissions.
Variable direct hospital costs are associated with items dispensed to patients during the hospital course (as opposed to fixed costs related to hospital facilities and staff) and can be saved by the hospital if a service is not provided. 22 Examples include medication, test reagents and disposable supplies. Cost data were supplied by the hospital accounting department. Average variable direct hospital costs per OPAT readmission were calculated using all readmissions within each study period.
Laboratory tests for each patient were evaluated and categorized into three groups: no laboratory tests received, partial laboratory tests received and all laboratory tests received. Laboratory tests received 2 weeks late or later were not counted. Laboratory tests status for patients whose OPAT duration was 3 weeks or longer was considered complete if two-thirds of the laboratory tests were received, none if no laboratory tests were received or only for a single week, and partial otherwise. For patients whose OPAT duration was 2 weeks or shorter, laboratory tests status was considered complete if all laboratory tests were received, none if no laboratory tests were received, and partial otherwise. Opioid dependence was determined by searching the administrative database for patients with an ICD-10 diagnosis of chronic iv or oral opioid dependence (F11.10, 11.20, 11.23, 11.90 or F19.10).
Statistical analysis
Baseline characteristics and outcomes for pre-RN and post-RN OPAT patients were compared using Fisher's exact test for categorical covariates 
Sensitivity analyses
We performed two sets of sensitivity analyses to test the robustness of our findings. First, we evaluated a model for inpatient OPAT discharges only that included APR-DRG and point of origin in addition to the covariates included in the model of the primary analysis for readmission. Second, we changed the intervention start date to 15 April 2016 to account for when the RN was being trained for the position and repeated the primary analysis.
Results
Patient inclusion and baseline characteristics
From 1 November 2013 to 31 June 2017, 517 OPAT patients were included in the analysis (Figure 1 ). Demographic and clinical characteristics were similar between groups, with three exceptions: more female patients (47.3%) were supervised by the RN compared with pre-RN (37.5%), there were more outpatient starts post-RN compared with pre-RN (5.3% and 1.6%, respectively) and opioid dependence was higher post-RN compared with pre-RN (18.2% and 7.1%, respectively) ( Table 2) .
Post-intervention outcomes
The readmission rate pre-RN was 20.2% compared with 13.3% post-RN (P " 0.04) (Figure 2) . The results of the adjusted model indicated that RN was associated with a 39% reduction in the risk of readmission (aRR 0.61; 95% CI 0.41-0.91; P " 0.01) ( Table 3) . There was no statistically significant difference between pre-and post-RN in the laboratory tests status. Overall, all laboratory tests were received for slightly over half of the patients. The association between RN and missing all laboratory tests was not statistically significant (aRR 1.13; 95% CI 0.82-1.56; P " 0.44).
Although the proportion of patients with wrong laboratory tests was lower post-RN compared with pre-RN, the difference was not statistically significant (31.1% and 41.2%, respectively; P " 0.09) (Figure 2) . Similarly, the association between RN and receiving wrong laboratory tests was not statistically significant (aRR 0.78; 95% CI 0.56-1.08; P " 0.13) ( Table 3) .
There was no difference in missing ID clinic appointments preand post-RN. Approximately 35% of OPAT patients missed at least one ID clinic appointment pre-and post-RN (Figure 2) . Likewise, the association between RN and missing at least one ID clinic appointment was not statistically significant (aRR 0.94; 95% CI 0.70-1.26; P " 0.69). The site of care was contacted for 48% of OPAT patients post-RN, compared with 16% pre-RN. Post-RN, site of care was three times more likely to be contacted compared with pre-RN (aRR 3.02; 95% CI 2.13-4.29; P , 0.001).
Results of our financial evaluation estimated that the reductions in readmissions achieved by the RN model saved the hospital $649 416 in inpatient costs over 15 months. The annual costs of the programme were $90 000, well below the estimated cost savings (Table 4) .
Sensitivity analyses
When inpatient OPAT discharges were examined separately, RN was associated with a 41% reduction in the risk of readmission (aRR 0.59; 95% CI 0.39-0.87; P , 0.01) ( Table 5) . Additionally, the association between RN and the risk of readmission was insensitive to the intervention start date (aRR 0.57; 95% CI 0.39-0.86; P , 0.01) ( Table 6 ). The same was observed for the study secondary outcomes.
Discussion
Our study demonstrates that an RN-managed OPAT model can reduce hospital readmissions and save hospital costs. Our findings of reduced readmissions remained significant despite an increase in the number of opiate-dependent patients in the post-intervention period. In the current era of value-based purchasing and reimbursement penalties for readmissions within 30 days postdischarge, the care of OPAT patients is increasingly important.
The nurse-managed model offers a number of advantages over a physician/nurse practitioner or pharmacist-managed model of OPAT care. First, using a solo practitioner as the primary OPAT Mansour et al.
manager is not financially sustainable given the lack of billing codes for the majority of OPAT-related activities. A nurse is better suited to perform OPAT monitoring functions, including side-effect management and disease counselling, than a pharmacist. Our model significantly reduced the effort required on the part of the ID specialist by triaging laboratory values, responding to patient concerns and performing documentation. This resulted in substantial cost savings to the hospital in our brief analysis. Figure 2 . Descriptive comparisons of primary and secondary outcomes for OPAT patients before and after the OPAT RN. Wrong laboratory tests, missed ID appointment and site of care contacted were assessed for a subset of patients (n " 348). Wrong laboratory tests were assessed for patients with all or partial laboratory tests only. Nurse-driven OPAT and readmission
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The creation of a nurse case manager-managed OPAT team significantly reduced hospital readmissions in our patient population, compared with the solo practitioner model, whereas laboratory receipts and clinic follow-up rates remained unchanged. The reasons for the reduction in readmissions in the post-intervention period are likely multifactorial. Given the finding of previous studies showing that laboratory availability was a key driver of readmissions, 15 the RN prioritized laboratory acquisition, spending up to 8 h per week placing phone calls to facilities. Despite this expenditure of effort, laboratory receipts did not improve, which is not unexpected since no incentive structure exists to reward or penalize outside agencies for communicating results.
We hypothesize other activities may have resulted in the reduction in readmissions, including establishing a line of communication for patients within the hospital intake visit and the behaviour contract for opioid-dependent patients. During the initial visit, the patient received the RN's contact information for emergency issues and extensive counselling about what to expect during the OPAT course and whom/when to call. This information was frequently utilized by patients with side effects, difficulty navigating the healthcare system and patients with signs of worsening infection. This communication pathway likely averted visits to the emergency department and subsequent hospital admissions. Second, the behaviour contract for opioid-dependent patients set an expectation of compliance that may have reduced illicit substance use via vascular access. Since complications of vascular access are a leading cause of readmission in OPAT patients, 3 this intervention may have pre-empted a number of line events.
Comparing our programme outcomes with those from more unified healthcare systems such as the NHS in the UK reveals several insights. A review of global OPAT outcomes from 2014 noted unplanned readmission rates ranging from of 3.6% to 11.7% at UK sites, 25 below what we see in even well-coordinated programmes such as Cleveland Clinic (15%) in the USA. 26 Other academic centres in the USA report readmission rates well over 20%. [27] [28] [29] [30] The UK has two major features which simplify OPAT delivery compared with private hospitals in the USA and which may account for lower readmission rates. First, in single-payer systems inpatient and outpatient incentives are aligned and investments in postdischarge care coordination accrue in cost savings to the whole system. 3 Second, OPAT in the UK is delivered exclusively at home with home nursing 3 whereas 46% of patients in our hospital were discharged to SNFs. SNFs have their own medical records, nursing staff and physicians who have no obligation to communicate patient results or treatment plan changes back to the hospital ID practice. Efforts by the OPAT programme to receive copies of these results and medication changes represent redundancy and inefficiency in the care coordination process. Communication processes are cumbersome and expensive, with our nurse spending 6-8 h weekly on the phone requesting results instead of directing her energy and expertise toward patient care. Systems innovations are sorely needed to streamline care coordination and communication for patients in SNFs.
Although this study demonstrates the effectiveness of a nursemanaged OPAT model, it is not without its limitations. First, as in any observational study, our results may be confounded by Mansour et al.
unmeasured patient or programme characteristics such as changes in clinical practices or case severity before and after the implementation of the nurse-managed OPAT programme. Nevertheless, our results remained largely unchanged from when the sensitivity analyses were performed (Tables 5 and 6 ). Second, readmissions to any facility not part of the Johns Hopkins Health System were not captured in this study. Preliminary analyses of statewide readmissions data suggest that this outside readmission rate is less than 3%, which is unlikely to significantly impact our conclusions. And lastly, we did not capture adverse event rates, clinical cure rates or source of infection owing to resource limitations of the new programme. These are metrics that we plan to evaluate in the future.
Conclusions
Our study highlights the importance of hospital investment in OPAT programmes, which provide a critical but largely non-billable set of functions for a complex group of patients. Given the high barriers to OPAT implementation in the USA, policymakers and hospital administrators need to find ways to incentivize high-quality post-discharge care for these patients. Nurse-managed programmes have shown positive outcomes and cost profiles in other disease states [31] [32] [33] [34] and could play an important role in the management of OPAT patients.
